{
"ranked_hypotheses": [
{
"title": "Structure-Based Targeting of the NACore β-Sheet Interface (Reframed as Fibril Elongation Inhibitor)",
"description": "Computational design targeting the NACore (residues 68–78) steric zipper interface critical for β-strand stacking and fibril elongation. Reframed from nucleation targeting to fibril end-capping based on Skeptic critique demonstrating that cryo-EM structures (6H6B) represent mature fibril end-states, not nucleation intermediates. Designed binders would occupy the self-complementary interface driving elongation, functioning as dominant-negative caps on growing fibril ends rather than blocking primary nucleation. Incorporates polymorphic fibril structures to account for strain diversity.",
"target_gene": "SNCA",
"composite_score": 0.65,
"evidence_for": [
{"claim": "NACore is minimal aggregation-prone segment; G73A mutation reduces aggregation kinetics", "pmid": "15475202"},
{"claim": "Peptide inhibitors derived from NACore block fibril formation in cellular models", "pmid": "19815675"},
{"claim": "Cryo-EM structures provide high-resolution template for binder docking", "pmid": "31036965"}
],
"evidence_against": [
{"claim": "Cryo-EM structures represent end-states not nucleation intermediates; structural continuity not demonstrated", "pmid": "31036965"},
{"claim": "Familial PD mutations distributed throughout protein, suggesting multiple nucleation surfaces", "pmid": "12595690"},
{"claim": "C-terminal truncations accelerate aggregation, indicating region outside NACore contributes to nucleation", "pmid": "11592929"}
]
},
{
"title": "Rational Design of Aggregation Competing Sequences as Dominant-Negative Competitors",
"description": "Incorporation of computed aggregation-blocking sequences into designed scaffolds (40–80 residue minibinders) that function as dominant-negative competitors. These sequences mimic the C-terminal aggregation interface (residues 100–140) but integrate into designed binder scaffolds rather than fibrils, acting as molecular sponges that cap growing fibril ends or sequester wild-type αS. Peptide-based inhibitors derived from this region demonstrate efficacy in cellular models; designed scaffolds improve stability and cellular delivery.",
"target_gene": "SNCA",
"composite_score": 0.62,
"evidence_for": [
{"claim": "C-terminal fragments accelerate aggregation; peptide inhibitors from this region show efficacy", "pmid": "11737276"},
{"claim": "C-terminal region facilitates cross-β interactions in fibril formation", "pmid": "23831613"},
{"claim": "Designed scaffolds can improve stability and cellular delivery over free peptides", "pmid": "30626073"}
],
"evidence_against": [
{"claim": "C-terminal truncations accelerate aggregation, suggesting this region may promote nucleation kinetics", "pmid": "11592929"},
{"claim": "Aggregation-blocking sequences may themselves aggregate if not properly scaffolded", "pmid": "22101819"}
]
},
{
"title": "Oligomer-Specific Surface Epitope Blockade",
"description": "Computational design of binders recognizing transient quaternary surfaces unique to spherical αS oligomers—distinct from monomeric αS or mature fibrils—exploiting the toxic oligomer hypothesis. These binders sterically occlude membrane-permeabilizing interfaces or block templated seeding surfaces. Limited by the transient nature of oligomers making structural characterization difficult and accurate computational targeting challenging.",
"target_gene": "SNCA",
"composite_score": 0.55,
"evidence_for": [
{"claim": "Conformation-specific antibodies (ASyn295, NJ001) validate oligomers display unique surfaces", "pmid": "23643722"},
{"claim": "Oligomers exhibit distinct biological activities from monomers and fibrils", "pmid": "20167329"},
{"claim": "Toxic oligomer hypothesis supported by multiple cellular and animal models", "pmid": "21254973"}
],
"evidence_against": [
{"claim": "Transient oligomer nature makes structural characterization difficult for accurate computational targeting", "pmid": "25636995"},
{"claim": "Oligomer population heterogeneity complicates identification of druggable surfaces", "pmid": "28720782"}
]
},
{
"title": "Cryptic Pocket Stabilization to Prevent Conformational Conversion",
"description": "De novo design of minibinders (40–80 residue scaffolds) targeting cryptic allosteric pockets on monomeric αS that, when stabilized, trap the protein in a non-aggregation-competent conformation. Uses ensemble-based modeling or AlphaFold2-generated conformational states to identify pockets that shift the monomer ensemble away from β-sheet-prone states. Limited by computational challenges in designing for intrinsically disordered targets where pocket identification depends on sampled conformational states.",
"target_gene": "SNCA",
"composite_score": 0.45,
"evidence_for": [
{"claim": "EGCG remodels aggregates demonstrating ligand-induced conformational changes are possible", "pmid": "22365486"},
{"claim": "AlphaFold2 can generate conformational states for IDP pocket identification", "pmid": "34758328"},
{"claim": "Ensemble-based modeling approaches show promise for IDP targets", "pmid": "33424157"}
],
"evidence_against": [
{"claim": "αS monomers adopt heterogeneous conformations; pocket identification depends on sampled states", "pmid": "33424157"},
{"claim": "Designing for intrinsically disordered targets remains computationally challenging", "pmid": "34758328"},
{"claim": "Binding-induced conformational selection may not prevent aggregation if kinetics favor β-sheet formation", "pmid": "22365486"}
]
}
],
"synthesis_summary": "TheSynthesized ranking prioritizes H1 (NACore β-sheet interface targeting, score 0.65) as the most evidence-supported approach, reframed as a fibril elongation inhibitor rather than nucleation blocker based on Skeptic analysis demonstrating that cryo-EM structures represent end-states. H4 (aggregation competing sequences, score 0.62) ranks second with strong peptide-inhibitor precedent and improved scaffold design potential. H2 (oligomer-specific targeting, score 0.55) benefits from conformation-specific antibody validation but faces transient oligomer characterization challenges. H3 (cryptic pocket stabilization, score 0.45) remains most speculative due to computational IDP challenges. Key knowledge gaps include: primary vs. secondary nucleation distinction affecting all hypotheses, polymorphic fibril strain diversity requiring multi-target strategies, and validation pathway for BBB penetration in therapeutic development. Falsification experiments using seeded growth kinetics with substoichiometric seed ratios will differentiate fibril-end capping (H1, H4) from nucleation blocking mechanisms.",
"knowledge_edges": [
{"source_id": "H1", "source_type": "hypothesis", "target_id": "H4", "target_type": "hypothesis", "relation": "shares_fibril_end_targeting_strategy"},
{"source_id": "H2", "source_type": "hypothesis", "target_id": "H1", "target_type": "hypothesis", "relation": "oligomer_targeting_supplements_fibril_elongation_inhibition"},
{"source_id": "H3", "